[ Price : $8.95]
FDA issues a Form FDA-483 to Aurobindo Pharma, citing three observations after investigators inspected the firms Unit XI, an activ...[ Price : $8.95]
The 7th Circuit Court of Appeals affirms a lower court decision dismissing a suit charging that AbbVies filing of 132 additional H...[ Price : $8.95]
Federal Register notice: FDA seeks comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact ...[ Price : $8.95]
Speaking at an Alliance for a Stronger FDA Webcast, FDA principal deputy commissioner Janet Woodcock says FDA is working toward ne...[ Price : $8.95]
Former CDER combination product team leader Jay Jariwala joins the Sidley law firm.[ Price : $8.95]
Merck and Eisai say the combination of Keytruda and Lenvima failed to meet two primary endpoints in a test of patients with unrese...[ Price : $8.95]
Some 99 health-related advocacy and service groups call on Congress to resume consensus talks on user fee reauthorization legislat...[ Price : $8.95]
Pfizer discontinues developing PF-07265803 in patients with symptomatic dilated cardiomyopathy after an interim futility analysis ...